Next Article in Journal
A Novel Site of Insertion of IS6110 in the moaB3 Gene of a Clinical Isolate of Mycobacterium tuberculosis
Previous Article in Journal
Vancomycin intermediate and high level vancomycin resistant Staphylococcus aureus clinical isolates in Osogbo, Nigeria
 
 
Microbiology Research is published by MDPI from Volume 11 Issue 2 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Does CCR5 gene-D32 deletion protect C.trachomatis infected Indian women from tubal pathology?

by
Jayanti Mania-Pramanik
1,*,
Shilpa C. Kerkar
1,
Anjali Vallabhadas
1,
Pratibha B Mehta
1 and
Vinita Salvi
1
1
National Institute for Research in Reproductive Health
2
Seth G.S.Medical College and K.E.M.Hospital
*
Author to whom correspondence should be addressed.
Microbiol. Res. 2011, 2(1), e5; https://doi.org/10.4081/mr.2011.e5
Submission received: 22 May 2011 / Revised: 22 May 2011 / Accepted: 22 May 2011 / Published: 3 August 2011

Abstract

Deletion in chemokine receptor CCR5 gene is reported to prevent development of tubal pathology among Dutch Caucasian C. trachomatis infected women. Hence, a pilot study was undertaken, to evaluate the involvement of CCR5 gene in tubal pathology among Indian women with or without Chlamydia infection. Three hundred women with or without Chlamydia infection and with different reproductive manifestations were screened for CCR5 gene using a standardized PCR. Only 6 C. trachomatis infected women without tubal block had heterozygous deletion for this gene. The rest had wild type CCR5 gene, that includes fertile women infected and non infected; infertile women infected and non infected with and without tubal block as well as infected women with history of recurrent spontaneous abortions. The study indicates no role of heterozygous CCR5 D32 gene deletion in prevention of tubal pathology in Chlamydia infected Indian women. Only 2% heterozygous deletion in CCR5 gene is observed in the studied population.
Keywords: CCR5; Chlamydia; Tubal Infertility CCR5; Chlamydia; Tubal Infertility

Share and Cite

MDPI and ACS Style

Mania-Pramanik, J.; Kerkar, S.C.; Vallabhadas, A.; Mehta, P.B.; Salvi, V. Does CCR5 gene-D32 deletion protect C.trachomatis infected Indian women from tubal pathology? Microbiol. Res. 2011, 2, e5. https://doi.org/10.4081/mr.2011.e5

AMA Style

Mania-Pramanik J, Kerkar SC, Vallabhadas A, Mehta PB, Salvi V. Does CCR5 gene-D32 deletion protect C.trachomatis infected Indian women from tubal pathology? Microbiology Research. 2011; 2(1):e5. https://doi.org/10.4081/mr.2011.e5

Chicago/Turabian Style

Mania-Pramanik, Jayanti, Shilpa C. Kerkar, Anjali Vallabhadas, Pratibha B Mehta, and Vinita Salvi. 2011. "Does CCR5 gene-D32 deletion protect C.trachomatis infected Indian women from tubal pathology?" Microbiology Research 2, no. 1: e5. https://doi.org/10.4081/mr.2011.e5

APA Style

Mania-Pramanik, J., Kerkar, S. C., Vallabhadas, A., Mehta, P. B., & Salvi, V. (2011). Does CCR5 gene-D32 deletion protect C.trachomatis infected Indian women from tubal pathology? Microbiology Research, 2(1), e5. https://doi.org/10.4081/mr.2011.e5

Article Metrics

Back to TopTop